GLP-1 receptor agonists -- the class of medications driving dramatic weight-loss results for millions of patients -- are reshaping far more than waistlines. As patients lose significant weight in compressed time frames, the face changes too: Volume diminishes; skin laxity increases; and the relationship between teeth, lips, and facial contours shifts in ways that can complicate aesthetic treatment planning considerably.